Short communication: Effect of estrogen supplemented at dry-off on temporal changes in concentrations of lactose in blood plasma of Holstein cows.

The objective was to determine the effect of supplemental estrogen (estradiol cypionate, ECP) at dry-off on temporal changes in concentrations of lactose in blood plasma of Holstein cows as an indicator of rate of mammary involution. Thirty-two Holstein cows (8/group) were assigned randomly to 4 treatment groups: 30-d dry, 30-d dry + ECP, 60-d dry, and 60-d dry + ECP. A single injection (7.5 mL) of cottonseed oil (30- and 60-d dry) or ECP (15 mg) in oil (30- and 60-d dry + ECP) was administered intramuscularly at dry-off. Blood samples were collected from the coccygeal vein of all cows 24 h before dry-off and at dry-off, and then 8 samples were collected throughout the subsequent 48 h to monitor concentrations of lactose in blood plasma. No significant effects of ECP on the overall mean concentrations of lactose were detected. Concentrations of lactose increased and were greatest in blood collected 20 h (520.4 +/- 54.1, 268.1 +/- 48.2, 345.0 +/- 52.3, 418.4 +/- 49.8 microM, for the 4 treatment groups respective to the order listed above) after supplemental ECP and final milk removal. At 40 h, concentrations approached those observed 24 h before dry-off (140.5 +/- 52.1, 57.6 +/- 47.1, 90.1 +/- 51.4, 61.2 +/- 48.4 microM, respectively). Concentrations of lactose at 20 h were positively correlated with milk yield of cows at dry-off. Similar temporal profiles of lactose in blood plasma of cows supplemented or not with ECP indicated that ECP at dry-off did not markedly alter the course of tight junction leakage that typically occurs in mammary epithelial tissue during progressive early involution when milk removal is discontinued.

Supplementing Holstein cows with low doses of bovine somatotropin prepartum and postpartum reduces calving-related diseases.

The objective of this study was to evaluate whether supplementing Holstein cows with bovine somatotropin (bST; 142.8 mg/14 d), beginning at 21 d (+/-3 d) before expected calving and continuing through 42 d in milk (+/-3 d), affected the incidence rates of retained fetal membranes (RFM), metritis (MET), clinical mastitis (MAS), digestive problems (DIG), ketosis (KET), milk fever (MF), displaced abomasum (DA, left or right), lameness (LAM), or number of sick cows during the first 60 d in milk. Data for multiparous Holstein cows from 3 separate trials were merged for analyses (n = 437). Cows in the bST-supplemented group (n = 162) received biweekly subcutaneous injections of Posilac, whereas control cows (n = 166) and a group of cohorts (n = 109) were not supplemented. Incidences of disease were collected from the herd health records. Across all treatment groups, the incidence rates (number of diseased cows divided by the total number of cows) for RFM, MET, MAS, DIG, KET, MF, DA, and LAM were 8.47, 18.31, 16.02, 4.35, 4.35, 3.66, 3.20, and 3.66%, respectively. The incidence rates of RFM, MET, MAS, DIG, KET, MF, DA, and LAM for cows in the bST-supplemented, control, and cohort groups were 6.79, 7.83, and 11.93%; 16.05, 7.47, and 22.94%; 10.49, 18.07, and 21.10%; 1.23, 5.42, and 7.34%; 1.23, 6.02, and 6.42%; 2.47, 4.22, and 4.59%; 2.47, 3.61, and 3.67%; and 3.70, 3.61, and 3.67%, respectively. The percentages of sick cows (number of cows having one or more cases of disease divided by the total number of cows) in the bST-supplemented, control, and cohort groups were 33.95, 43.37, and 49.54%, respectively. Significant chi-squared values were detected between the bST-supplemented and control groups for MAS, DIG, and KET, with a greater number of healthy cows in the bST-supplemented group. No differences in incidences of diseases or sick cows were detected between the control and cohort groups. Results indicated that a low dose of bST supplemented to Holstein cows for 3 wk prepartum through 60 d in milk reduced the incidences of some calving-related diseases compared with nonsupplemented controls or cohorts. Importantly, no negative effects of bST supplementation on postpartum calving diseases were detected compared with nonsupplemented cows.

Milk production from Holstein half udders after concurrent thirty- and seventy-day dry periods.

The objective of this study was to use a within-cow, half-udder model to compare the effect of cessation of milk removal from mammary quarters within respective half udders at either 30 or 70 d before expected calving date (ECD) on the ability of the half udders to subsequently produce milk. Pregnant Holstein cows were assigned to control (n = 14) or treatment (TRT, n = 26) groups. All mammary quarters in the udder of cows in the control group had 70-d (68 +/- 9 d) dry periods, whereas in each cow of the TRT group, 1 randomly selected half udder was dried at 70 d before ECD and the other half udder continued to be milked twice daily until dried at 30 d before ECD. From 80 through 70 d before ECD, amounts of milk produced by the left and right half udders of cows in the TRT group were measured at the first-shift milking. No differences were detected in the actual or relative amounts of milk produced by the left (3.46 +/- 0.2 kg; 48.8 +/- 1.0%) and the right (3.63 +/- 0.2 kg; 51.2 +/- 1.0%) half udders. Furthermore, the actual and relative amounts of milk produced by the half udders (n = 12 left, 14 right) subsequently dry for 67 +/- 7 d (3.56 +/- 0.2 kg; 50.2 +/- 1.0%) and the half udders (n = 14 left, 12 right) subsequently dry for 27 +/- 7 d (3.54 +/- 0.2 kg; 49.8 +/- 1.0%) did not differ before they were dried. However, from 3 to 100 d of the subsequent lactation, the 30-d dry half udders produced 18.9% less milk than the 70-d dry half udders (16.3 vs. 20.1 +/- 1.0 kg/d). In addition, relative amounts of total-udder milk produced by the 30- and 70-d dry half udders in the same cow differed (44.9 vs. 55.1 +/- 0.2%, respectively). Cows in the control group produced more milk than cows in the TRT group through 80 DIM (39.5 vs. 35.2 +/- 0.6 kg/d), but not from 3 through 150 DIM (39.0 vs. 36.2 +/- 1.6 kg/d). Thus, half udders that produced the same actual and relative amounts of milk before being dried did not do so when given a 30-d dry period instead of a 70-d dry period. When compared with the pre-dry value (49.8%), the relative contribution of half udders dry for 30 d to the total milk yield during the first 100 DIM was decreased by 9.8%.

Pregnancy and bovine somatotropin in nonlactating dairy cows: I. Ovarian, conceptus, and insulin-like growth factor system responses.

Nonlactating dairy cows were used to examine effects of bovine somatotropin (bST) on components of the insulin-like growth factor (IGF) system. Estrus was synchronized in cows with a Presynch + Ovsynch protocol and timed AI (TAI; n = 55) or not TAI (cycling, C; n = 23) on d 0 (time of synchronized ovulation). On d 0 and 11, cows received bST (500 mg) or no bST, and were sacrificed on d 17. Pregnancy rates were less in bST cows (27.2%, 9 of 33) than in controls (63.6%; 14 of 22). In contrast, conceptuses were larger in bST-treated cows (39.2 +/- 4.8 cm) than in controls (20 +/- 4.3 cm). Total interferon-tau in uterine luminal flushings (ULF) was greater in bST-treated cows (7.15 > 2.36 microg). Number of class 2 follicles (6 to 9 mm) was less in bST-C cows on d 7 and 16. On d 17, corpus luteum (CL) weight tended to be greater in bST-treated cows. Concentrations of progesterone were greater after d 10 in C than in pregnant (P) cows. In the ULF, IGF-binding protein-3 was greater in bST-P cows than in pregnant cows. A tendency for an increase in IGF-I hormone concentrations in the ULF was detected on d 17 in bST-treated and cyclic cows. Endometrial mRNA for IGF-I, IGF-II, IGFBP-2, and IGFBP-3 increased in bST-C, but not in bST-P cows. Treatment with bST increased plasma concentrations of insulin, IGF-I, and growth hormone (GH). In conclusion, bST may have hyperstimulated plasma IGF-I and insulin to cause asynchrony between conceptus and uterus that was detrimental to pregnancy.

Low doses of bovine somatotropin during the transition period and early lactation improves milk yield, efficiency of production, and other physiological responses of Holstein cows.

The objectives of this experiment were to determine whether low doses of bovine somatotropin (bST) during the transition period and early lactation period improved dry matter intake (DMI), body weight (BW), or body condition score (BCS); provoked positive changes in concentrations of somatotropin, insulin, insulin-like growth factor-I (IGF-I), glucose, nonesterified fatty acids, and Ca; or improved milk yield (MY) response without obvious adverse effects on health status. Eighty-four multiparous Holstein cows completed treatments arranged in a 2 x 3 x 2 factorial design that included prepartum and postpartum bST, dry period (30 d dry, 30 d dry + estradiol cypionate, and 60 d dry), and prepartum anionic or cationic diets. Biweekly injections of bST began at 21 +/- 3 d before expected calving date through 42 +/- 2 d postpartum (control = 0 vs. bST = 10.2 mg of bST/d; POSILAC). At 56 +/- 2 d in milk, all cows were injected with a full dose of bST (500 mg of bST/14 d; POSILAC). During the prepartum period and during the first 28 d postpartum, no differences in mean BW, BCS, or DMI were detected between the bST treatment group and the control group. During the first 10 wk of lactation, cows in the bST treatment group had greater mean MY and 3.5% fat-corrected milk yield and lower SCC than did cows in the control group. When cows received a full dose of bST, an increase in milk production through wk 21 was maintained better by cows in the bST group. Mean concentrations of somatotropin, IGF-I, and insulin differed during the overall prepartum period (d -21 to -1). During the postpartum period (d 1 to 28), cows in the bST group had greater mean concentrations of somatotropin and IGF-I in plasma. Concentrations of Ca around calving did not differ because of bST treatment. Results suggest that changes in concentrations of blood measures provoked by injections of bST during the transition period and early lactation period resulted in improved metabolic status and production of the cows without apparent positive or negative effects on calving or health.

Responses of Holstein cows to a low dose of somatotropin (bST) prepartum and postpartum.

Objectives were to evaluate the effects of a low dose of bovine somatotropin (bST) injected prepartum and postpartum on body condition score (BCS), body weight (BW), and milk yield (MY) in cows as well as somatotropin insulin, insulin-like growth factor-I (IGF-I), glucose, and nonesterified fatty acids (NEFA) in plasma. Holstein cows nearing second or later parities were assigned randomly to control (CON = 98) or bST-treated (TRT = 95) groups. Biweekly injections of bST began 21 +/- 3 d before expected calving and continued through 42 d postpartum (CON vs. TRT; 0 vs. 10.2 mg of bST/ d). From 42 to 100 d postpartum, no cows received bST. During yr 1, somatotropin, IGF-I, insulin, NEFA, and glucose were measured in plasma samples from 82 cows. During yr 2, effects of bST on BCS and BW of 111 cows were evaluated, but no blood samples were collected. Milk yields through 100 d of all 193 cows were analyzed. Prepartum treatment with bST resulted in greater prepartum plasma concentrations of somatotropin, insulin, and numerically greater NEFA but did not affect glucose or IGF-I. Postpartum bST increased mean plasma concentrations of somatotropin and NEFA, but not INS, IGF-I, or glucose. Mean BCS of cows did not differ prepartum, around parturition, or postpartum. Although mean BW did not differ prepartum or around calving, cows receiving bST maintained greater BW postpartum. Cows receiving bST tended to have higher MY (6.6%) in the first 60 d of lactation, but differences did not persist through 100 d, including approximately 40 d when no cows received bST. Number of cows that were culled due to health (CON = 3 vs. TRT = 2) or died (CON = 3 vs. TRT = 1) were not affected by treatment. Low doses of bST in the transition period resulted in higher postpartum BW, quicker recovery of body condition during lactation, and significantly more milk during treatment.

Milk production and feed intake of Holstein cows given short (30-d) or normal (60-d) dry periods.

Eighty-four Holstein cows were utilized to evaluate effects of dry period (60 d vs. 30 d), with or without estradiol cypionate (ECP) injections to accelerate mammary involution, on prepartum and postpartum dry matter intake (DMI), body weight (BW), body condition score (BCS), and subsequent milk yield (MY). Treatments were arranged in a 3 x 2 x 2 factorial design that included dry period (30 d dry, 30 d dry + ECP, and 60 d dry), prepartum and postpartum bovine somatotropin (bST; 10.2 mg/d), and prepartum anionic or cationic diets. To accelerate mammary involution, ECP (15 mg) was injected intramuscularly at dry-off. No interaction of bST or prepartum diet with dry period length was detected on BW, BCS, or MY. No significant effects of dry period length on prepartum DMI, BW, or BCS were detected. Cows with shorter dry periods maintained postpartum BCS better and tended to have greater DMI immediately postpartum. Mean daily yields of milk for dry period groups did not differ during overall lactation period (1 to 21 wk). Injection of ECP at the onset of the 30-d dry period did not affect MY. No significant differences due to dry period length were detected for milk, 3.5% FCM, or SCM yields during first 10 wk of lactation. Data indicated that a short dry period protocol can be used as a management tool with no loss in the subsequent milk production of dairy cows.

Effects of whole cottonseed diet and recombinant bovine somatotropin on ovarian follicles in lactating dairy cows.

The effects of whole cottonseed (WCS) in the diet and the administration of bovine somatotropin (bST) on ovarian follicular dynamics and plasma progesterone (P4) concentrations were examined in cows during a period of synchronized follicular growth. Lactating Holstein cows (n = 28) were randomly assigned to treatments in a 2 x 2 factorial arrangement. Diets consisted of WCS (15% of dry matter) or no WCS, and bST at a dose of 0 or 208 mg/14 d. Dietary treatments began within 24 h of calving and bST treatments began within 7 d postpartum. Cows received GnRH at 65 +/- 3 d postpartum (d 0), PGF2alpha, (d 7), a second dose of GnRH (d 9), and were inseminated 16 h later (d 10). Ovarian changes were monitored daily by ultrasonography from d 0 to 9. On d 9,93% of cows had a preovulatory follicle and 86% ovulated. For Class 2 (6 to 9 mm) follicles, a diet x bST interaction was detected, with bST stimulating Class 2 follicles in cows fed WCS, but not in cows on the control diet. Neither diet nor bST affected numbers of Class 1 (2 to 5 mm) or Class 3 (> or = 10 mm) follicles or sizes of the subordinate and dominant follicles. During the luteal phase of the cycle, lactating cows fed WCS tended to have elevated concentrations of plasma P4, whereas bST was without effect. Plasma concentrations of high-density lipoprotein cholesterol were increased in cows fed WCS. Number and diameter of corpora lutea did not differ among treatments.

Southeastern pasture-based dairy systems: housing, posilac, and supplemental silage effects on cow performance.

This experiment tested performance and physiological responses to evaporative cooling, bovine somatotropin (bST), and supplemental silage of lactating cows grazing bermudagrass (Tifton 85; Cynodon dactylon x C. nlemfuensis cv.) pastures. Multiparous (n = 32) cows (196 d in milk) were assigned one of five treatments arranged in two replicates. Treatments were 1) cows maintained continuously on pasture with access to shade, 2) treatment 1 + bST, 3) night housing on pasture, then free-stall housing with fans and misters from 0730 to 1630 h, 4) treatment 3 + bST, and 5) treatment 4 + corn silage fed at 0.5% of body weight (dry matter basis) in the barn. A grain supplement was fed at a rate of 0.5 kg/kg of milk produced. Time spent grazing ranged from 4 to 7.2 h/d, with cows fed corn silage spending the least amount of time. Cows given bST grazed 45 min/d longer than controls, but intake of bermudagrass was unchanged. Intake of bermudagrass ranged from 7.4 to 9.5 kg/d of organic matter, with the lowest intake by cows fed corn silage. With the exception of cows fed corn silage, cows kept in a cooling barn during the day ate equivalent amounts of pasture as those given unlimited access to pasture. Production of 4% fat-corrected milk was greater by cows injected with bST (17.7 vs. 15.8 kg/d) compared with controls and tended to be greater for cows given daytime cooling compared with cows on pasture continuously (17.2 vs. 16.3 kg/d). Cows provided evaporative cooling did not lose weight compared with continually pastured cows (6.3 vs. -10.9 kg/24 d). Cows injected with bST compared with controls maintained their body weight better (2.5 vs. -7.1 kg/24 d). Cows given bST had increased concentration of plasma insulin-like growth factor-I (142 vs. 89 ng/ml), insulin (0.60 vs. 0.56 ng/ml), and nonesterified fatty acids (318 vs. 239 mEq/L). Cows given bST and those continually on pasture had greater diurnal body temperatures. Use of barn cooling systems and bST treatments as management tools provided limited improvement in performance of midlactation cows managed in pasture-based systems.

Effects of prepartum dry matter intake and forage percentage on postpartum performance of lactating dairy cows.

The objective of this research was to determine whether different dry matter intakes (DMI) or forage percentages prepartum would have an impact on postpartum performance. Multiparous Holstein cows (n = 41) received either high (H) or low (L) forage rations that were fed free choice (F) or restricted (R), i.e., HF, HR, LF, and LR. The L rations were higher in net energy of lactation and lower in neutral detergent fiber concentrations. After calving, all cows were fed the same ration ad libitum. Prepartum DMI were 8.0 for R versus 12.4 kg/d for F with LF greater than HF (14.1 vs. 10.7 kg/d). Prepartum treatments did not affect postpartum means for DMI, milk yield, milk protein percentage, body weight, body condition score, or plasma glucose concentrations (overall means 1 to 40 DIM were, respectively, 21.1 kg/d, 34.0 kg/d, 3.03%, 624 kg, 3.2, and 66 mg/dl). However, curves from 1 to 40 DIM showed that DMI and milk yield were slightly higher in early lactation in cows whose DMI had been restricted prepartum but mean milk fat percentage was lower (3.10 vs. 3.42%). Plasma NEFA were higher and insulin lower in H versus L before and after calving. High DMI prepartum, at best, showed no advantage over restricted feeding.

Milk plasmin during bovine mammary involution that has been accelerated by estrogen.

The purpose of this study was to evaluate whether the plasminogen and plasmin system within bovine mammary secretions was influenced by an estrogen treatment that was used to accelerate mammary tissue involution. Holstein cows were injected with 4 ml of ethanol excipient (n = 21) or 15 mg of estradiol-17 beta (n = 23) on each of the 4 d that preceded final milk removal. Dates of final milk removal (d 0) were designated as 60 d prior to expected dates of calving. Each mammary quarter was sampled once to collect secretions that corresponded to d 0, 3, 11, and 25 or d 1, 7, 18, and 30 of the dry period. Concentrations of plasminogen, plasmin, and somatic cells in secretions increased earlier for treated cows than for control cows. The ratio of plasminogen to plasmin in secretions decreased earlier for treated cows than for control cows. These responses support the suggestion that the plasminogen and plasmin system is involved in the involution of bovine mammary tissue. Estrogen treatment increased the activation of plasminogen, which was evidenced by a precipitous decrease in the ratio of plasminogen to plasmin that occurred as concentrations of plasminogen and plasmin increased. The activation of plasminogen likely contributed to the increased rate of mammary tissue involution that was effected by exogenous estrogen. Endogenous estrogen secreted by the developing fetal and placental unit might mediate, in part, the gradual involution that occurs during lactation.

Factors affecting human placenta and birth weights and vitality of newborns in a subtropical environment

Os fatores que afetam o peso de nascimento e da placenta e a vitalidade de recém-nascidos humanos na Flórida foram avaliados em bancos de dados de 1480 (conjunto de dados I) e 788 (conjunto de dados II) casos. Este último conjunto foi uma subdivisäo do primeiro, tendo menos casos devido a procedimentos de seleçäo mais rígidos. Estes procedimentos excluíram natimortos ou fetos com valores muito elevados ou baixos em qualquer variável de resposta, sendo que estes últimos foram entäo considerados como casos anormais. Os fatores avaliados afetaram significativamente as variáveis de resposta na maioria dos casos, mas näo necessariamente em ambos os conjuntos de dados. No conjunto de dados II, efeitos do mês do parto foram detectados em todas as variáveis exceto vitalidade aos 5 min. pós- parto (valor II de Apgar). O peso da placenta foi 112g menor nos meses quentes do que nos meses frios. A vitalidade em 1 min. pós-parto (valor I de Apgar) foi afetada pelo mês mas näo de modo sistemático. Os recém-nascidos do sexo masculino tiveram pesos 45g maiores para placenta, para peso corporal (142g) e para peso total (187g). O grupo étnico afetou todas as respostas, exceto o peso placentário. Efeitos da paridade foram detectados para todas as respostas, exceto peso placentário e valor II de Apgar; a duraçäo da gestaçäo afetou todas as respostas, exceto o peso placentário. Os pesos placentário e do recém nascido correlacionaram-se intensamente com sua soma (correlaçäo de parte com o todo), mas näo um com o outro nem com os valores de Apgar. Estes correlacionaram-se intensamente um com o outro. O conhecimento das características das variáveis de resposta e dos fatores que as influenciam deve contribuir consideravelmente para o conhecimento geral dos fatores que afetam as características dos nascimentos humanos.

Estrogen administered at final milk removal accelerates involution of bovine mammary gland.

To evaluate whether estrogen hastened involution of mammary tissue, Holstein cows were injected with 4 ml of ethanol excipient (n = 21) or 15 mg of estradiol-17 beta (n = 23) on each of the 4 d that preceded final milk removal. Dates of final milk removal (d 0) were designated as 60 d prior to expected dates of calving. Milk volumes were recorded, and samples were collected prior to the first and fourth injections. During the dry period, each mammary quarter within the cow was sampled once to collect secretions on dates that corresponded to d 0, 3, 11, and 25 or 1, 7, 18, and 30 of the dry period. Milk synthesis and secretion declined abruptly because of treatment. The decreased concentrations of alpha-lactalbumin, lactose, citrate, and potassium in secretions of controls, as well as the increased somatic cells, protein, lactoferrin, and sodium, occurred earlier in secretions from treated cows. These shifts of approximately 6 d, relative to days dry, suggested that exogenous estradiol increased the involution rate of mammary tissue.

Effects on production of milking three times daily on first lactation Holsteins and Jerseys in Florida.

First lactation DHI records of 4293 Holstein and 2143 Jersey cows from 14 herds for 1984 through 1992 in Florida were studied to estimate effects on milk, fat, and protein yields of milking three times daily. Analyses were by derivative-free REML using the animal model. Advantages of milking three times daily for 305 d compared with milking twice daily were 1226 (17.3%), 29 (12.3%), and 19 kg (8.8%) for the milk, fat, and protein yields for Holsteins, respectively, and 284 (6.3%), 13 (6.2%), and 7 kg (4.3%) for Jerseys. Additional research is needed to evaluate effects on other economically important traits such as composition, health, and reproduction. Economic studies are required to determine the efficacy of milking three times daily, especially for Jerseys with their relatively low response.

Effects of concentration of dietary phosphorus on amount and route of excretion.

Objectives were to determine the effect of dietary concentration of P in DM on routes of excretion of P and to evaluate direct and indirect measures of calculating DM digestibility and P excretion. Twelve lactating Holstein cows were fed 20 kg of DM containing .41% P daily for 4 wk and then were assigned randomly to one of three diets: low (.30%), medium (.41%), or high (.56%) in P for 9 wk. Total collections of excreta (feces and urine) and milk were made during wk 4, 7, 10, and 13. At wk 4, cows excreted 88.2% of P consumed daily: 68.6% of excreted P in feces, 1.0% in urine, and 30.3% secreted in milk. Cows assigned to the low P diet decreased intake by 26.8% and excretion of P in feces by 22.7% in wk 13 compared with wk 4, whereas cows fed the high P diet increased intake by 36.5% and excretion of P in feces by 48.6%. Digestibility of DM was 62.6% when calculated from total collection of feces but only 55.7 or 56.5% when estimated indirectly using Cr or acid detergent lignin as indigestible markers. Apparent excretion of P was less than that estimated using either of the marker techniques (49.7 vs. 59.1 and 58.1 +/- .7 g/d of P) because digestibility of DM was underestimated. A prediction equation was developed for P excretion based on P intake and milk production.

Milk yields and hormone concentrations of Holstein cows in response to sometribove (somatotropin) treatment during the dry period.

Holstein cows (n = 135) under commercial management were used to determine whether sometribove (recombinant methionyl bST, 25 mg/d) administered during the dry period affected milk yield during the ensuing lactation. Cows scheduled to begin lactations (greater than or equal to 2) during January to March were assigned randomly to treatments of sodium bicarbonate excipient (n = 67) or bST (25 mg/d, n = 68). Subcutaneous injections were given for 14 d, corresponding to d -21 to -7 relative to expected calving date. Days dry prior to first injection (64.0, 60.2) and number of injections received (13.9, 13.8) were similar for control and treatment groups, but days from last injection to calving (8.8, 7.1) differed. No differences in incidence of dystocia or udder edema were detected. Previous lactation yields were 8251 and 7952 kg, and yields for lactations following treatment were 8328 and 7852 kg, based on complete lactation data. Mean test date 3.5% FCM yields for control and treated groups during experimental lactation differed before (30.3 vs. 28.1 kg) but not after (29.5 vs. 28.4 kg) covariance adjustment for previous total lactation milk yield. Test of heterogeneity of regression provided no evidence that respective curves for FCM yield during lactation were not parallel or of different magnitude. Elevation of serum bST during 2 wk of the dry period resulted in no apparent increase in extent of mammogenesis or lactogenesis that was translated into an increase in milk yield.

Disappearance of phosphorus in phytate from concentrates in vitro and from rations fed to lactating dairy cows.

Objectives were to determine concentrations of P in phytate in selected concentrates, disappearance of P in phytate from these concentrates in vitro, and extent of hydrolysis of phytate in vivo. Total P and P in phytate were determined for eight concentrates; 32 to 81% of total P was in phytate. Six concentrates were incubated in vitro to determine the extent of phytate disappearance from solids and its appearance and disappearance from solution. Greater than 90% of P in phytate disappeared from solids between 6 and 8 h of incubation in vitro (wheat middlings, rice bran, hominy, soybean meal, and dried distillers grains) or between 12 and 24 h (cottonseed meal). Phosphorus in phytate in solution was hydrolyzed by 12 h except for cottonseed meal (by 24 h). Hydrolysis of the inositol ring to release P in vivo was greater than 99%, based on total fecal collection from 11 cows and the use of Cr as an indigestible marker in excreta, and between 94 to 98% for the same samples when acid detergent lignin was used as an indigestible marker to calculate phytate disappearance. These results further indicate that P in phytate should be considered available to lactating dairy cows when rations to meet their P requirements are being formulated.

Follicular dynamics, plasma metabolites, hormones and insulin-like growth factor I (IGF-I) in lactating cows with positive or negative energy balance during the preovulatory period.

The effect of dietary energy balance (EB) on growth of ovarian follicles was tested. Cows (n = 9) were fed a high energy diet (HE diet; positive EB; n = 4) or switched to a low energy diet (LE diet; negative EB; n = 5) during the preovulatory period. Non-esterified fatty acids (NEFA) were greater in cows fed the LE diet. Concentrations of luteinizing hormone (LH) were similar in HE and LE cows. However, the growth of preovulatory follicles in cows fed the LE diet was 50% that of cows fed the HE diet. Insulin-like growth factor-I (IGF-I) in plasma was less in LE-fed cows compared with HE-fed cows, and plasma IGF-I was positively correlated to estrogen: progesterone ratio in follicular fluid of dominant follicles. In summary, slower follicular growth in cows fed an LE diet occurred despite normal plasma LH and coincided with reduced IGF-I and elevated NEFA in plasma.

Evaluation of sometribove in a prolonged-release system in lactating dairy cows--production responses.

Primiparous (n = 105) and multiparous (n = 136) Holstein cows were used to evaluate efficacy of sometribove (n-methionyl bovine somatotropin, bST) in a dose titration study. Cows were fed TMR for ad libitum intake, were milked twice daily, and were allocated randomly within parity (1 vs. 2+) to treatments of 0, 250, 500, or 750 mg bST/14 d in a prolonged-release formulation. Subcutaneous injections commenced 60 +/- 3 d postpartum and continued throughout lactation. During a standardized treatment period of 252 d, treatment with increasing dosages of bST increased 3.5% FCM yield in a dose-dependent manner for both primiparous (2.5 kg/d, 10.2%; 3.5 kg/d, 14.3%; and 5.9 kg/d, 24.1%) and multiparous cows (3.1 kg/d, 12.1%; 3.9 kg/d, 15.2%; and 6.8 kg/d, 26.5%). Milk content of fat, protein, lactose, ash, Ca and P, and SCC were not affected by treatment. Over the 252-d treatment period, voluntary intake of energy was increased in bST-treated cows such that BW gain, body condition score, and net energy balance did not differ among treatment groups. Productive efficiency (milk per unit NEL intake corrected for BW change) over the treatment period was significantly increased in a dose-dependent manner for multiparous cows (4.1, 6.8, and 11.0%). Results demonstrated that bST administered in a prolonged-release formulation was efficacious in enhancing milk production and feed efficiency.

Actions of bovine somatotropin on polymorphonuclear leukocytes and lymphocytes in cattle.

Objectives were to determine 1) in vitro effects of bST on function of polymorphonuclear leukocytes and lymphocytes and 2) in vivo effects of bST on leukocyte function of heifers fed to maintain medium or high growth rates. When administered in vitro, bST did not affect function of polymorphonuclear leukocytes. [Methyl-3H]thymidine incorporation by resting lymphocytes was stimulated by 1000 ng/ml bST. When given in vitro, bST did not further enhance [methyl-3H]thymidine uptake by mitogen-stimulated lymphocytes cultured at 38.5 degrees C but reduced the depression of mitogen-stimulated proliferation caused by incubating cells at 42 degrees C. When bST was administered in vivo, phagocytosis and killing of Escherichia coli by polymorphonuclear leukocytes from bST-treated heifers were not different from cells of control heifers. As measured by [methyl-3H]thymidine uptake after stimulation with phytohemagglutinin, lymphocytes from bST-treated heifers responded similarly to those of control heifers when incubated at 38.5 degrees C, but the depression in [methyl-3H]thymidine uptake due to culture at 42 degrees C was less for lymphocytes obtained from bST-treated heifers. In conclusion, bST had little effect on function of polymorphonuclear leukocytes but could promote proliferation of lymphocytes in vitro and protect cells from effects of elevated temperature.